Top

Category: Vaccines


Industry, Vaccines

Study Finds Delta Somewhat Resistant to Vaccines — What About Omicron?

December 3, 2021

Via: Drugs.com

Lab studies show that the mutations found in COVID-19’s Delta variant make the virus more resistant to existing vaccines, a potentially ominous development as the new Omicron variant starts to wend its way around the world. Full vaccination with the […]


Industry, Vaccines

Vaccine Industry Applies Lessons from the COVID-19 Response

December 3, 2021

Via: Genetic Engineering and Biotechnology News

The vaccine industry recognized the potential of mRNA vaccines as far back as the 1980s.1 It anticipated that mRNA molecules could be synthesized in large quantities more quickly and cheaply than proteins.2 And it also knew that mRNA vaccines would […]


Industry, Vaccines

COVID-19 Shakes Up Vaccine Production

December 3, 2021

Via: Genetic Engineering and Biotechnology News

Vaccines are among the hottest topics in biopharmaceuticals today. At the time of this article’s writing, 49.5% of the world’s population have already received at least one dose of a COVID-19 vaccine, and 26.65 million doses are being administered each […]


Industry, Vaccines

Sanofi to acquire Origimm Biotechnology to develop acne vaccine

December 2, 2021

Via: European Pharmaceutical Review

Sanofi has announced that it entered into an agreement to acquire Origimm Biotechnology, an Austrian privately owned biotechnology company specialising in the discovery of virulent skin microbiome components and antigens from bacteria causing skin disease, such as acne. The transaction […]


Industry, Vaccines

Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response

December 1, 2021

Via: World Pharma News

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of […]


Industry, Vaccines

COVID-19 vaccines against Omicron may be fast-tracked

November 30, 2021

Via: PMLiVE

Attention is turning to the vaccines that most developed countries are relying on to control the COVID-19 pandemic, asking two key questions: will the existing vaccines work against Omicron and, iIf not, how quickly can manufacturers ‘tweak’ them to boost […]


Industry, Vaccines

Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant

November 30, 2021

Via: FiercePharma

As the world assesses the threat posed by the COVID-19 omicron variant, two top companies producing pandemic drugs and vaccines have warned that their current offerings may not be effective against the variant. On Tuesday, Regeneron sounded (PDF) a disquieting […]


Industry, Vaccines

Pfizer to Seek FDA Approval of Boosters for Teens Ages 16-17

November 30, 2021

Via: Drugs.com

Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17. Sources familiar with the matter told The New York Times that the U.S. Food and Drug Administration could give […]


Industry, Vaccines

Pfizer, Moderna, J&J and AstraZeneca assess omicron’s effect on their COVID-19 vaccines

November 29, 2021

Via: FiercePharma

With the new omicron strain fueling fear around the globe that the coronavirus is regaining momentum, makers of the world’s most successful vaccines are investigating whether they need to tweak their shots. Over the last few days, Moderna, Pfizer-BioNTech, Johnson […]


Industry, Vaccines

COVID-19 tracker: FDA advisory group will discuss Merck antiviral; Companies test vaccines against new variant

November 29, 2021

Via: FiercePharma

Companies are testing their COVID-19 vaccines against the new variant, omicron. An FDA advisory committee will meet tomorrow to discuss its recommendation for Merck’s COVID-19 antiviral. The worldwide case count stood at more than 261.98 million Monday afternoon, with more […]


FDA, Industry, Regulations, Vaccines

Pfizer, Moderna score FDA nods for COVID boosters in all adults, setting up high-stakes CDC meeting

November 19, 2021

Via: FiercePharma

The race between Moderna and Pfizer to gain FDA nods for their COVID-19 vaccines as boosters in all adults has ended in a dead heat. On Friday morning, the FDA simultaneously expanded emergency use authorizations for both mRNA vaccines to […]


Industry, Vaccines

mRNA COVID-19 Vaccine Improved through mRNA Backbone Optimization

November 19, 2021

Via: Genetic Engineering and Biotechnology News

Two COVID-19 mRNA vaccines, made by BioNTech/Pfizer and Moderna, are helping to change the course of the COVID-19 pandemic. A third mRNA vaccine, developed by CureVac and known as CVnCoV, has not had the same success to date. Indeed, a […]